By and large, sponsors and other stakeholders now recognise the intrinsic benefits of DCTs in improving access to clinical trials and enhancing flexibility for patients. This recognition is ...

Each active clinical trial scoped to transition would need its own strategic roadmap, where stakeholders — sponsors, CROs, and sites — were on the same page at every step, including the ...

The U.S. Food and Drug Administration (FDA), and the Office of Human Research protections (OHRP) released draft guidance titled, “Considerations ...

The Swedish government will explore a national stakeholder partnership to increase the number of clinical trials in Sweden. The move comes after a decade of slow decline in trial applications ...

“The merger will enable us to even better serve all clinical trial stakeholders as we work with our new colleagues to redefine the site and patient experience,” said Jim Murphy. “By putting ...

The merger will enable us to even better serve all clinical trial stakeholders as we work with our new colleagues to redefine the site and patient experience. By putting these two industry ...